Genome Canada
Overview
Genome Canada is a federally funded, not-for-profit organization that invests in genomics research, innovation, data, and talent to generate solutions for challenges in health, agriculture, and the environment.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ProteinQure | Apr 2026 | Grant | Co-investor |
| OncoForma | Mar 2026 | Grant | Co-investor |
| Integrated Nanotherapeutics | Mar 2026 | Grant | Co-investor |
| Specific Biologics | Mar 2026 | Grant | Co-investor |
| Vasomune Therapeutics | Oct 2014 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genome Canada based?
Genome Canada is headquartered in Ottawa, Canada.
When was Genome Canada founded?
Genome Canada was founded in 2000.
How many portfolio companies does Genome Canada have?
Genome Canada has 10 portfolio companies in Caplight's dataset.
What are some companies in Genome Canada's portfolio?
Portfolio companies visible on Caplight include ProteinQure, OncoForma, Integrated Nanotherapeutics, Specific Biologics, Vasomune Therapeutics.
What was Genome Canada's most recent investment shown here?
Genome Canada's most recent investment in this portfolio sample was in ProteinQure in 2026.
What sectors does Genome Canada focus on?
Genome Canada focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Genome Canada focus on?
Genome Canada typically invests at the MultiStage stage.